Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension

Giornale Italiano di Cardiologia

Volumn 28, Issue 6, 1998, Pages 636-644

  Modena, Maria Grazia ^a,b   Rossi, Rosario ^a   Muia Jr , Nicola ^a   Origliani, Giorgia ^a   Rombolà, Olinda ^a   Molinari, Rosella ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Ischaemic heart disease; Menopause; Risk factors

Indexed keywords

CHOLESTEROL; ESTRADIOL; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYSTERECTOMY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTMENOPAUSE;

ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; DRUG THERAPY, COMBINATION; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPERTENSION; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE CONGENERS; RISK FACTORS; TIME FACTORS;

EID: 0031781020     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Health for All Database World Health Organization (WHO) http://wwwwhoorg
2. MENOTTI A: La prevenzione della cardiopatia coronarica Torino, II Pensiero Scientifico Editore, 1989, 7-53
3. THOM TJ, EPSTEIN FH, FELDMAN JJ, LEAVERTON PE, WOLZ M Total mortality and morbidity from heart disease, cancer and stroke from 1950 to 1987 in 27 countries highlight of trends and their interrelationship among causes of death NIH publication No. 92-3088 Bethesda, Md National Institutes of Health, National Heart, Lung and Blood Institute, 1992
4. HIGGINS M, THOM T: Trends in CHD in the United States Int J Epidemiol 1989, 19. 558-566
5. NAYLOR CD, CHEN E: Population-wide mortality trends among patients hospitalized for acute myocardial infarction, the Ontario experience, 1981 to 1991 J Am Coll Cardiol 1994, 24 1431-1438
6. GOLDMAN L, COOK EF The decline in ischemic heart disease mortality rates An analysis of the comparative effects of medical interventions and changes in lifestyle Ann Intern Med 1984, 101 825-836
7. MENOTTI A, SECCARECCIA F Epidemiologia delle malattie cardiovascolari in Italia. La Cardiologia nella Pratica Clinica 1997, 4 241-283
8. Measuring the risk of coronary heart disease in adult population groups a symposium Am J Public Health 1957; 47: 1-63
9. KANNEL WB: Metabolic risk factors for coronary heart diseases in women perspective from Framingham study. Am Heart J 1987, 114: 413-419
10. STOKES J, KANNEL WB, WOLF PA, D'AGOSTINO RB, CUPPLES LA Blood pressure as a risk factor for cardiovascular disease The Framingham study - 30 years of follow-up. Hypertension 1989, 13 (Suppl I). 13I-18I
11. WENGER NK Coronary heart disease in women risk factors, prevention, and treatment Cardiology 1997, 3 59-63
12. STAMPFER MJ, WILLETT WC, COLDITZ GA, ROSNER B, SPEIZER FE, HENNEKENS CH A prospective study of postmenopausal estrogen therapy and coronary heart disease N Engl J Med 1985, 313 1044-1049
13. STAMPFER MJ, COLDITZ GA, WILLETT WC, ET AL Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study N Engl J Med 1991, 325 756-762.
14. GRODSTAIN F, STAMPFER MJ, COLDITZ GA, ET AL Postmenopausal hormone therapy and mortality N Engl J Med 1997; 336 1769-1775.
15. STEVENSON JC, CROOK D, GODSLAND IF, LEES B, WHITEHEAD MI Oral versus transdermal hormonal replacement therapy Int J Fertil Menopausal Stud 1993, 38 30-35
16. WALSH BW, Li H, SACKS FM Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism J Lipid Res 1994, 35: 2083-2093
17. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) Arch Intern Med 1993; 153: 154-291.
18. FROHLICH ED, GRIM C, LABARTHE DR, ET AL Recommendations for human blood pressure determination by sphygmomanometers: report of a special task force appointed by the Steering Committee, American Heart Association Hypertension 1988, 11 209A-222A
19. NOTELOVITZ M Estrogen replacement therapy indications, contraindications, and agent selection Am J Obstet Gynecol 1989, 161: 1832-1841.
20. STOCKBRIDGE, HARDY AND GLUECK Blood pressure and its relationship to plasma lipids and lipoproteins. cross-sectional data from the FELS longitudinal study J Lab Clin Med 1989, 114/2; 142-151
21. HENRY RJ, HENRY M Clinical chemistry 2 New York, Harper and Row Publishers, 1974
22. MCGOWAN MW, ARTISS JD, STRANDBERGH DR, ZAK B: A procedure for the determination of high-density lipoprotein containing phospholipids Clin Chem 1983, 29 538.
23. CAEN J, LARRIEU MJ, SAMAMA M L'hemostase. Methode d'esploration et diagnostic pratique Paris, L'Expansion Scientifique, 1975
24. CONOVER WW: Practical nonparametric statistics New York, John Wiley and Sons, 1980
25. CROSIGNANI PG Management of hormonal replacement therapy the Italian experience Eur J Obstet Gynecol Reprod Biol 1996, 64 (Suppl) 13-15
26. PFEFFER RI, VAN DEN NOORT S Estrogen use and stroke risk in postmenopausal women Am J Epidemiol 1976, 103 445-456
27. AVILA MH, WALKER AM, JICK H: Use of replacement estrogens and the risk of myocardial infarction Epidemiology 1990, 1 128-133
28. WRITING GROUP OF THE PEPI TRIAL Effects of estrogen or estrogen/progesterone regimens on heart disease risk factors in postmenopausal women the Postmenopausal Estrogen/Progesterone Interventions (PEPI) trial JAMA 1995, 273 199-208
29. GRADY D, RUBIN SM, PETITTI DB, ET AL Hormonal therapy to prevent disease and prolong life in postmenopausal women Ann Intern Med 1992, 117 1016-1037
30. STAMPFER MS, COLDITZ GA Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence Prev Med 1991, 20: 47-63
31. GRODSTEIN F Can selection bias explain benefits of hormonal replacement therapy? Am J Epidemiol 1996, 143 979-982
32. VENDENBROUCKE JP How much of the cardioprotective effect of postmenopausal estrogen is real? Epidemiology 1995; 6: 207-208
33. POSTHUMA WFM, WESTENDORP RGJ, VANDENBROUCKE JP Cardioprotective effect of hormone replacement therapy in postmenopausal women is the evidence biased? Br Med J 1994, 308: 1268-1269
34. TILLY KIESI M, KAHRI J, PYORALA T, ET AL Responses of HDL subclasses, Lp(A-I) and Lp(A-I.A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progesterone and transdermal estrogen with cyclic progesterone regimens in postmenopausal women Atherosclerosis 1997, 129 249-259
35. LAHDENPERA S, PUOLAKKA J, PYORALA T, LUOTOLA H, TASKINEN MR Effects of postmenopausal estrogen/progesterone replacement therapy on LDL particles, comparison of transdermal and oral treatment regimens Atherosclerosis 1996, 122 153-162
36. O'SULLIVAN AJ, HO KK A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women J Clin Endocrinol Metab 1995, 80 1783-1788
37. LOBO RA: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women J Clin Endocrinol Metab 1991, 73 925-1560
38. O'BRIEN T, NGUYEN TT Lipids and lipoprotein in women Mayo Clin Proc 1997, 72 235-244
39. GILLIGAN DM, QUYYUMI AA, CANNON RO Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women Circulation 1994, 89 2545-2551
40. BARRETT-CONNOR E, BUSH TL Estrogen and coronary heart disease in women J Am Med Assoc 1991, 265 1861-1867
41. ROSSELLI M, IMTHURN B, KELLER PJ, JACKSON EK, DUBEY RK Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 β-estradiol and norethisterone acetate A two years follow-up study Hypertension 1995, 25 848-853
42. WINKLER UH Menopause, hormone replacement therapy and cardiovascular disease: a review of haemostaseological findings Fibrinolysis 1992; 6 (Suppl 3). 5-10
43. HASSAGER C, CHRISTIANSEN C Blood pressure during oestrogen progestogen substitution therapy in healthy postmenopausal women Maturitas 1988, 9: 315
44. PFEFFER RI Estrogen use, hypertension and stroke in postmenopausal women J Chron Dis 1978, 31 389-398
45. STAESSEN JA, BIENIASZEWSKI L, BROSEN I, FAGARD R The epidemiology of menopause and associated cardiovascular disease In STIMPEL M, ZANCHETTI A (eds) Hypertension after menopause Berlin, New York, de Gruyter, 1997
46. LIP GYH, BEEVERS M, CHURCHILL D, BEEVERS DG Hormonal replacement therapy and blood pressure in hypertensive women J Hum Hypertens 1994, 8: 491-494
47. PFEFFER RI, KUROSAKI TT, CHARLTON SK Estrogen use and blood pressure in later life Am J Epidemiol 1979, 110: 469-478
48. CRANE MG, HARRIS JJ, WINSOR J Hypertension, oral contraceptive therapy and conjugate oestrogens Ann Intern Med 1971, 74 13-21.
49. KAPLAN NM The Deadly Quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension Arch Intern Med 1989, 149 1514-1520
50. KANNEL WB, MCGEE DL Diabetes and glucose tolerance as risk factors for cardiovascular disease the Framingham Study Diabetes Care 1978, 2 120-126
51. TIENGO A, DEL PRATO S: La sindrome plurimetabolica associazione di diabete, dislipidemia ed ipertensione arteriosa Cardiologia 1995, 40 237-243
52. VUORINEN-MARKKOLA H, YKI-JARVINEN H Hyperuricemia and insulin resistance J Clin Endocrinol Metab 1994, 78 25-29
53. BUSH T The epidemiology of cardiovascular disease in postmenopausal women Ann N Y Acad Sci 1990, 592 263-271.
54. EPSTEIN FE Cardiovascular disease epidemiology Circulation 1996, 93 1755-1764